Mirae Asset Global Investments’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $31.1K | Buy |
3,324
+468
| +16% | +$4.38K | ﹤0.01% | 1328 |
|
|
2025
Q1 | $37.6K | Buy |
2,856
+12
| +0.4% | +$158 | ﹤0.01% | 1296 |
|
|
2024
Q4 | $36.3K | Sell |
2,844
-234
| -8% | -$2.99K | ﹤0.01% | 1320 |
|
|
2024
Q3 | $58.1K | Buy |
3,078
+541
| +21% | +$10.2K | ﹤0.01% | 1277 |
|
|
2024
Q2 | $51.6K | Sell |
2,537
-37,731
| -94% | -$767K | ﹤0.01% | 1243 |
|
|
2024
Q1 | $893K | Sell |
40,268
-6,629
| -14% | -$147K | ﹤0.01% | 1601 |
|
|
2023
Q4 | $1.01M | Buy |
46,897
+4,705
| +11% | +$102K | ﹤0.01% | 1613 |
|
|
2023
Q3 | $613K | Buy |
42,192
+2,700
| +7% | +$39.2K | ﹤0.01% | 1783 |
|
|
2023
Q2 | $821K | Buy |
39,492
+615
| +2% | +$12.8K | ﹤0.01% | 1688 |
|
|
2023
Q1 | $821K | Buy |
38,877
+13,430
| +53% | +$284K | ﹤0.01% | 1643 |
|
|
2022
Q4 | $648K | Buy |
25,447
+1,957
| +8% | +$49.8K | ﹤0.01% | 1739 |
|
|
2022
Q3 | $565K | Buy |
23,490
+7,255
| +45% | +$175K | ﹤0.01% | 1801 |
|
|
2022
Q2 | $313K | Buy |
+16,235
| New | +$313K | ﹤0.01% | 1967 |
|